GSC
ANRO icon

Ground Swell Capital’s Alto Neuroscience ANRO Stock Holding History

Ground Swell Capital’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-12,447
Closed -$27.4K – 251
2025
Q2 		$27.4K Buy
+12,447
New +$29.6K 0.04% 83

Other funds holding ANRO

AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ground Swell Capital's ANRO Position: Q3 2025 in Review

Ground Swell Capital sold out of Alto Neuroscience (ANRO) in Q3 2025, closing a stake of 12,447 shares — an estimated $27.4K sold.

Ground Swell Capital first reported a position in ANRO in Q2 2025 and held it in 1 quarter. The position peaked at $27.4K in Q2 2025. 77 funds tracked by Wall St. Rank hold ANRO as of Q3 2025.

  • Ground Swell Capital reported no remaining Alto Neuroscience position as of Q3 2025 after selling out during the quarter.
  • Ground Swell Capital sold 12,447 Alto Neuroscience shares in Q3 2025, an estimated $27.4K.
  • Ground Swell Capital first reported a position in Alto Neuroscience in Q2 2025 and held it in 1 quarter.
  • Ground Swell Capital's Alto Neuroscience position peaked at $27.4K in Q2 2025.
  • 77 funds tracked by Wall St. Rank held Alto Neuroscience as of Q3 2025.

Based on Ground Swell Capital's 13F filing for Q3 2025, filed 6 Nov 2025.